Dr. Hughes and Mr. Klemperer and Dr. Schuurmans rightly point to the limits of the generalizability of our study's findings. When designing a randomized, controlled trial, selecting a particular intervention and choosing what to compare it with is always difficult. Smoking reduction is a complex issue—many possible ways and scenarios to achieve reduction are available, which may result in varying success rates. This strategy is in contrast to abrupt quitting, which allows for less opportunity for variation. Therefore, the general question of whether trying to reduce consumption ahead of a target quit date is counterproductive may have no ...
Cheong Y, Yong HH, Borland R. Does how you quit affect success? A comparison between abrupt and gradual methods using data from the International Tobacco Control Policy Evaluation Study. Nicotine Tob Res. 2007;9:801-10. [PMID: 17654293] CrossrefMedlineGoogle Scholar
Ebbert JO, Hughes JR, West RJ, Rennard SI, Russ C, McRae TD, et al. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. JAMA. 2015;313:687-94. [PMID: 25688780] doi:10.1001/jama.2015.280 CrossrefMedlineGoogle Scholar
Lindson-Hawley N, Shinkins B, West R, Michie S, Aveyard P. Does cigarette reduction while using nicotine replacement therapy prior to a quit attempt predict abstinence following quit date? Addiction. 2016;111:1275-82. [PMID: 26990374] doi:10.1111/add.13330 CrossrefMedlineGoogle Scholar
Author, Article, and Disclosure Information
From University College London, London, and University of Oxford, Oxford, United Kingdom.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-2805.